MedTrace Logo

Exploration of the VOLATOLOM in the Stable Severe COPD (Chronic Obstructive Pulmonary Disease)

NCT05029349 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-01-28

No results posted yet for this study

Summary

This is a prospective interventional study to determine whether the profile of volatile organic compounds (VOCs) present in exhaled air (VOLATOLOM) is reproducible in stable severe COPD (Chronic Obstructive Pulmonary Disease) patients.

Conditions

  • Chronic Obstructive Pulmonary Disease Severe

Interventions

DEVICE

VOC analysis

VOC analysis in exhaled air with e-noses and mass spectrometry.

Sponsors & Collaborators

  • Air Liquide SA

    collaborator INDUSTRY

  • Hopital Foch

    lead OTHER

Principal Investigators

  • Philippe Devillier, MD PhD · Hopital Foch

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-13
Primary Completion
2023-06-13
Completion
2023-06-13

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05029349 on ClinicalTrials.gov